The Global Lymphedema Treatment Market is estimated to be valued at US$ 1.98 Bn in 2023 and is expected to exhibit a CAGR of 9.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Lymphedema treatment involves self-care, physiotherapy and medical devices to manage accumulated fluid. Various devices like pneumatic compression pumps and multi-layer compression bandages are commonly used for lymph drainage and improved mobility.
Market key trends:
Increased awareness through social media and patient advocacy groups has drawn attention towards lymphedema treatment worldwide. Various physiotherapy techniques like manual lymph drainage and complete decongestive therapy help reduce limb swelling and symptoms significantly. Home-based pneumatic compression pumps are gaining popularity due to 24x7 convenience and comparable effectiveness to clinic-based treatment. Growing demand for minimally invasive procedures is also driving innovations in drug delivery and surgical options.
Segment Analysis
The global lymphedema treatment market is segmented into compression systems, pump therapy, surgical decompression procedures, others. The compression systems segment dominated the market in 2022 and is expected to continue its dominance over the forecast period. Compression systems are preferred as the front-line treatment for lymphedema as they provide effective long-term management of the condition. Types of compression systems include compression garments, compression bandages, and compression pumps.
Key Takeaways
The Global Lymphedema Treatment Market is expected to witness high growth, exhibiting CAGR of 9.9% over the forecast period 2023 to 2030, due to increasing prevalence of chronic diseases such as cancer that can lead to lymphedema. The market size for 2023 is US$ 1.98 Bn.
Regional analysis
The North America region dominated the global lymphedema treatment market in 2022 accounting for the largest revenue share of over 30%. Rising geriatric population and increasing awareness and diagnosis of lymphedema in the region is driving the market growth. The Asia Pacific region is expected to witness the fastest growth during the forecast period owing to growing healthcare infrastructure and rising medical tourism in countries like India and China.
Key players
Key players operating in the lymphedema treatment market are Tactile Medical, Bio Compression Systems, Essity Medical Solutions, Sigvaris Group, Lohmann & Rauscher, Mego Afek, ThermoTek, Medi GmbH, Compressel, Huntleigh Healthcare, JUZO, Bio Horizons, medi UK, ArjoHuntleigh, BSN Medical, Lympha Press, Paul Hartmann, Convatec, Herantis Pharma. Major players are focusing on new product launches and strategic collaborations to gain a competitive edge in the market.
Read More - https://www.rapidwebwire.com/lymphedema-treatment-market-growth-size-share
Global Lymphedema Treatment Market Research Report: By Type (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery) and By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) Forecast to 2027Market ScopeMarket Research Future (MRFR) studied the global lymphedema treatment market 2021 for the analysis tenure till 2025.
The rise in research activities for the development of new drugs to treat lymphedema drawing funds from top-notch investors for the commercialization of novel drug formulations.
The existing treatment of lymphedema i.e., surgery and radiation therapy, are not effective, as reappearance of lymphedema is often reported after months or years.
Thus, the inclination towards the need for effective drug for treating lymphedema can add impetus to the market growth.
Favorable reimbursement policies, along with the support of government for affording treatment, are additional causes that can benefit the lymphedema treatment market.
On the contrary, limited availability of treatment options for lymphedema can hinder the market rise.
Global Lymphedema Treatment Market Research Report: By Type (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery) and By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) – Forecast to 2025Global Market – OverviewThe increasing prevalence of cancer is expected to drive the Global Lymphedema Treatment Market.The strong clinical pipeline is likely to boost the market growth.
Market players like HERANTIS PHARMA PLC, are developing curative treatment of secondary lymphedema—Lymfactin.
Lymfactin is the world’s first and only clinical-stage gene therapy against lymphedema.
The market potential of the drug is estimated to be around USD 650 MillionKey Players3A Health Care (Italy)Bio Compression Systems, Inc. (US)Devon Medical Products (US)HERANTIS PHARMA PLC (Finland)Lohmann & Rauscher (Germany)Mego Afek Ltd (US)SIGVARIS (Switzerland)Tactile Systems Technology Inc. (US)Wright Therapy Products (BSN Medical) (Germany) Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/8440Market InfluencerIncreased research & development in the market is estimated to influence the commercialization in the market.
The market is projected to witness a shift from symptomatic treatments to targeted treatment during the forecast period of 2018 to 2025.Market DriversIncreasing cancer casesLymphedema is a medical condition characterized by extra fluid buildup in the body tissues, resulting in a blockage of the lymphatic system.It is reported that a majority of the lymphedema cases affect cancer patients.
However, in certain cases, lymphedema is reported after months or years of cancer treatment.
